He has held senior management positions previously at Merck, Circassia Pharmaceuticals, Durata Therapeutics, Horizon, Takeda Pharmaceuticals North America, NeoPharm, Searle/Pharmacia and Bristol-Myers Squibb, the release said. Gilmore has been with TerSera since the company's inception in 2016 and, prior to TerSera, served as vice president of marketing at Crealta Pharmaceuticals, which was acquired by Horizon, the release said. She's also worked at TAP Pharmaceuticals and Takeda Pharmaceuticals North America and spent the early part of her career at Arthur Andersen in the supply chain technology services practice, the release said. Hrdlicka serves South San Francisco-based Genentech by working with executive and legislative branch policymakers in several upper Midwest states to develop favorable policy toward biotechnology innovation, the release said.